Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intraluminal Implantation of Radioactive Stents for Treatment of Unresectable Biliary Tract Cancer

NCT02238613 is registered in ClinicalTrials.gov with 307 Hospital of PLA as lead sponsor.

NCT NCT02238613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02238613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intraluminal Implantation of Radioactive Stents for Treatment of Unresectable Biliary Tract Cancer
Lead sponsor
307 Hospital of PLA
Phase
Not applicable
Overall status
Unknown status
Start date
August 31, 2014
Completion date
June 30, 2017
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ampullary carcinoma, biliary obstruction, cholangiocarcinoma of the extrahepatic bile duct, intrahepatic cholangiocarcinoma